Acute Microbial Switch
NCT05764200 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2024-08-22
Summary
In this project the investigators will test if it is possible to measure changes in intestinal gas production after supplementation of a complex fiber mixture over a 36 hour period in both lean normoglycemic individuals and individuals with insulin resistance and/or prediabetes with overweight when compared with a placebo
Changes in intestinal gas production will also be related to energy expenditure, substrate metabolism, microbial composition and related metabolites in feces, blood and urine.
Conditions
- Insulin Sensitivity
- Glucose Metabolism Disorders (Including Diabetes Mellitus)
- Hyperinsulinism
Interventions
- DIETARY_SUPPLEMENT
-
Two day supplementation of a complex fiber mixture
Participants will undergo a two day supplementation of a complex fiber supplement vs. placebo with a two-week washout period between the two interventions in a randomized order
- DIETARY_SUPPLEMENT
-
Placebo supplementation
Participants will undergo a two day supplementation of a complex fiber supplement vs. placebo with a two-week washout period between the two interventions in a randomized order
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2025-10-31
- Completion
- 2025-10-31
Countries
- Netherlands
Study Locations
More Related Trials
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2
-
INtestinal Dysbiosis and TRanslocation of Bacteria in Patients Undergoing Surgery
NCT05775341 ·Status: ACTIVE_NOT_RECRUITING
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research
NCT06466707 ·Status: RECRUITING ·Phase: NA
-
PRObing The Efficacy of Commercial Stage Storage Buffers and Evaluating Gut Metaproteome Variability Between Individuals
NCT06423508 ·Status: RECRUITING
-
Gut Microbiota in Patients With Peripheral Arterial Disease and Chronic Limb-threatening Ischemia
NCT05757297 ·Status: NOT_YET_RECRUITING
-
Treatment of Bacterial Vaginosis
NCT00324818 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis
NCT04771728 ·Status: RECRUITING ·Phase: PHASE4
-
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
NCT04764500 ·Status: ACTIVE_NOT_RECRUITING
-
Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals
NCT02007343 ·Status: COMPLETED
-
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
NCT00573521 ·Status: COMPLETED
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
NCT03273296 ·Status: COMPLETED ·Phase: PHASE4
-
Phenotypic and Genotypic Variations of Enterococcus Spp
NCT05751317 ·Status: UNKNOWN
-
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
NCT04623424 ·Status: RECRUITING
-
Carriage Of Multiresistant Bacteria After Travel
NCT01676974 ·Status: COMPLETED
-
Westlake Sailing Cohort
NCT04611945 ·Status: COMPLETED
-
Implications of the Human Microbiota for Health and Disease
NCT04203303 ·Status: RECRUITING
-
Stool Transplantation to Reduce Antibiotic Resistance Transmission
NCT02461199 ·Status: UNKNOWN
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Clinical Metagenomic of Post-traumatic Infections
NCT05770856 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)
NCT00481702 ·Status: COMPLETED ·Phase: PHASE3
-
Intestinal Microbiota Composition After Antibiotic Treatment in Early Life
NCT02536560 ·Status: UNKNOWN
-
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
NCT00952796 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Intestinal Microbiota
NCT07058961 ·Status: RECRUITING